DISEASE INDICATIONS: Progeria

MANUFACTURER: Eiger Biopharmaceuticals

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Zokinvy (lonafarnib) is a medication used for treating Hutchinson-Gilford Progeria Syndrome (HGPS), a genetic disorder that accelerates aging in children. HGPS is caused by a mutation in the lamin A gene, leading to a build-up of a toxic protein called progerin in the body.